SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001564590-21-019477
Filing Date
2021-04-20
Accepted
2021-04-19 19:20:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 srne-424b3.htm 424B3 230700
2 GRAPHIC gkecdrgs3feg000001.jpg GRAPHIC 3210
3 GRAPHIC gkecdrgs3feg000002.jpg GRAPHIC 3210
  Complete submission text file 0001564590-21-019477.txt   240919
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-255165 | Film No.: 21835866
SIC: 2836 Biological Products, (No Diagnostic Substances)